logo
Overview
Discover
Watchlists
Portfolios
Heatmap
Sectors
Trendscore
Performers
Alerts
Options
Earnings
Screeners
Scanners
Backtests
Strategies
Comparisons
Charts
Sign in
Discover
AVTX
Avalo Therapeutics, Inc.
19.71
1 x 19.68
5 x 19.77
bid
ask
-
0.05
0.28%
01:40 PM
timesize
Ytd8.56%
1y118.81%
18.87
day range
19.98
8.41
52 week range
24.27
Open19.98Prev Close19.77Low18.87High19.98Mkt Cap1.04B
Vol394.95KAvg Vol1.48MEPS-4.37P/E-4.51Forward P/E-6.95
Beta0.80Short Ratio5.86Inst. Own75.28%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-1250-d Avg17.31200-d Avg16.621yr Est44.69

AVTX News

benzinga.com
Guggenheim Maintains Buy on Avalo Therapeutics, Lowers Price Target to $48

Guggenheim analyst Yatin Suneja maintains Avalo Therapeutics (NASDAQ:AVTX) with a Buy and lowers

benzinga.com
HC Wainwright & Co. Maintains Buy on Avalo Therapeutics, Lowers Price Target to $30

HC Wainwright & Co. analyst Mitchell S. Kapoor maintains Avalo Therapeutics (NASDAQ:AVTX) wit
benzinga.com
Avalo Therapeutics Q2 EPS $(0.83) Misses $(0.58) Estimate

Avalo Therapeutics (NASDAQ:AVTX) reported quarterly losses of $(0.83) per share which missed the ana

Avalo Therapeutics Reports Second Quarter 2026 Financial Results and Recent Business Updates
globenewswire.com
Avalo Therapeutics Reports Second Quarter 2026 Financial Results and Recent Business Updates

WAYNE, Pa., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical st

Avalo Therapeutics to Participate in the BTIG Biotechnology Conference
globenewswire.com
Avalo Therapeutics to Participate in the BTIG Biotechnology Conference

WAYNE, Pa., July 22, 2026 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical st

Avalo Therapeutics to Participate in the Leerink Partners Therapeutics Forum
globenewswire.com
Avalo Therapeutics to Participate in the Leerink Partners Therapeutics Forum

WAYNE, Pa. , July 07, 2026 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical s
benzinga.com
Leerink Partners Initiates Coverage On Avalo Therapeutics with Outperform Rating, Announces Price Ta

Leerink Partners analyst Thomas Smith initiates coverage on Avalo Therapeutics (NASDAQ:AVTX) with
benzinga.com
Avalo Therapeutics To Be Added To Small-Cap Russell 2000 Index And Broad-Market Russell 3000 Index,

Avalo Therapeutics, Inc. (NASDAQ:AVTX), a clinical stage biotechnology company fully dedicated to de

Avalo Therapeutics to Join the Russell 2000® and Russell 3000® Indexes
globenewswire.com
Avalo Therapeutics to Join the Russell 2000® and Russell 3000® Indexes

WAYNE, Pa., June 26, 2026 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical st

Avalo Therapeutics Appoints Ron Philip to Board of Directors
globenewswire.com
Avalo Therapeutics Appoints Ron Philip to Board of Directors

WAYNE, Pa., June 23, 2026 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical-st

12 Health Care Stocks Moving In Wednesday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
benzinga.com
Avalo Therapeutics Advances AVTX-010, Long-Acting Next-Gen Anti-IL-1β mAB With Potential For Develop

Avalo Therapeutics, Inc. (NASDAQ:AVTX), a clinical stage biotechnology company fully dedicated to de

Avalo Therapeutics Expands Pipeline with AVTX-010, a Long-Acting Next-Generation Anti-IL-1β Antibody
globenewswire.com
Avalo Therapeutics Expands Pipeline with AVTX-010, a Long-Acting Next-Generation Anti-IL-1β Antibody

WAYNE, Pa., June 16, 2026 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical st

This ICU Medical Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
benzinga.com
This ICU Medical Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

Top Wall Street analysts changed outlook on top names. Find all rating changes on Benzinga's ana

This FormFactor Analyst Turns Bullish; Here Are Top 3 Upgrades For Friday
benzinga.com
This FormFactor Analyst Turns Bullish; Here Are Top 3 Upgrades For Friday

Wall Street analysts upgraded EDU, MKTX, and FORM stocks. Check out their ratings on Benzinga's

This Sailpoint Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Friday
benzinga.com
This Sailpoint Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Friday

Wall Street analysts downgrade ADBE and SAIL, cutting price targets. Check other analysts' views

This Keurig Dr Pepper Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
benzinga.com
This Keurig Dr Pepper Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Frid

Top Wall Street analysts changed their outlook on top names. See analyst rating changes for PepsiCo,
benzinga.com
B of A Securities Initiates Coverage On Avalo Therapeutics with Buy Rating, Announces Price Target o

B of A Securities analyst Alec Stranahan initiates coverage on Avalo Therapeutics (NASDAQ:AVTX) w

Avalo Therapeutics Announces Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
Avalo Therapeutics Announces Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)

WAYNE, PA., May 22, 2026 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical sta
benzinga.com
Citizens Maintains Market Outperform on Avalo Therapeutics, Lowers Price Target to $55

Citizens analyst Jason N. Butler maintains Avalo Therapeutics (NASDAQ:AVTX) with a Market Outperf

These Analysts Revise Their Forecasts On Avalo Therapeutics After Q1 Results
benzinga.com
These Analysts Revise Their Forecasts On Avalo Therapeutics After Q1 Results

Avalo Therapeutics reported better-than-expected Q1 loss due to positive trial results. Analysts mai
benzinga.com
Wedbush Maintains Outperform on Avalo Therapeutics, Lowers Price Target to $34

Wedbush analyst Robert Driscoll maintains Avalo Therapeutics (NASDAQ:AVTX) with a Outperform and

Apple To Rally More Than 22%? Here Are 10 Top Analyst Forecasts For Thursday
benzinga.com
Apple To Rally More Than 22%? Here Are 10 Top Analyst Forecasts For Thursday

Analyst ratings for top names changed: Doximity cut to neutral, National Vision lowered price target
benzinga.com
Mizuho Maintains Outperform on Avalo Therapeutics, Raises Price Target to $45

Mizuho analyst Joseph Catanzaro maintains Avalo Therapeutics (NASDAQ:AVTX) with a Outperform and

benzinga.com
HC Wainwright & Co. Maintains Buy on Avalo Therapeutics, Lowers Price Target to $35

HC Wainwright & Co. analyst Mitchell S. Kapoor maintains Avalo Therapeutics (NASDAQ:AVTX) wit
benzinga.com
Avalo Therapeutics Q1 EPS $(0.98) Beats $(1.13) Estimate

Avalo Therapeutics (NASDAQ:AVTX) reported quarterly losses of $(0.98) per share which beat the analy

Avalo Therapeutics Reports First Quarter 2026 Financial Results and Recent Business Updates
globenewswire.com
Avalo Therapeutics Reports First Quarter 2026 Financial Results and Recent Business Updates

WAYNE, Pa., May 13, 2026 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX) (“Avalo”), a cl
benzinga.com
Piper Sandler Maintains Overweight on Avalo Therapeutics, Raises Price Target to $60

Piper Sandler analyst Yasmeen Rahimi maintains Avalo Therapeutics (NASDAQ:AVTX) with a Overweight

Avalo Therapeutics Stock Soars After Positive LOTUS Trial Results
benzinga.com
Avalo Therapeutics Stock Soars After Positive LOTUS Trial Results

Avalo Therapeutics Inc (NASDAQ:AVTX) shares are surging after the company delivered a major clinical

12 Health Care Stocks Moving In Wednesday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Wednesday's Intraday Session

Davita, Bloomin' Brands, Compass And Other Big Stocks Moving Higher On Wednesday
benzinga.com
Davita, Bloomin' Brands, Compass And Other Big Stocks Moving Higher On Wednesday

Dow Jones up 500 points, DaVita Inc (DVA) shares rise after better-than-expected earnings and raised
benzinga.com
Citizens Maintains Market Outperform on Avalo Therapeutics, Raises Price Target to $62

Citizens analyst Jason N. Butler maintains Avalo Therapeutics (NASDAQ:AVTX) with a Market Outperf
benzinga.com
Wedbush Maintains Outperform on Avalo Therapeutics, Raises Price Target to $40

Wedbush analyst Robert Driscoll maintains Avalo Therapeutics (NASDAQ:AVTX) with a Outperform and

12 Health Care Stocks Moving In Wednesday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
benzinga.com
Market-Moving News for May 6th

AMD: 21% | Advanced Micro Devices shares are trading higher after the company reported better-than-e
benzinga.com
BTIG Maintains Buy on Avalo Therapeutics, Raises Price Target to $58

BTIG analyst Julian Harrison maintains Avalo Therapeutics (NASDAQ:AVTX) with a Buy and raises the

Why Veeco Instruments Shares Are Trading Higher By 21%; Here Are 20 Stocks Moving Premarket
benzinga.com
Why Veeco Instruments Shares Are Trading Higher By 21%; Here Are 20 Stocks Moving Premarket

Veeco Instruments Inc (NASDAQ: VECO) rose in pre-market trading after reporting Q1 results and affir

Avalo Therapeutics Stock Jumps 33% In Pre-Market Session: Here's Why
benzinga.com
Avalo Therapeutics Stock Jumps 33% In Pre-Market Session: Here's Why

Avalo Therapeutics Inc. rises sharply in pre-market trading following a Phase 2 trial win and a $375

Avalo Therapeutics Announces Pricing of $375 Million Public Offering
globenewswire.com
Avalo Therapeutics Announces Pricing of $375 Million Public Offering

WAYNE, Pa., May 05, 2026 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (NASDAQ: AVTX) (“Avalo”), a cl
benzinga.com
Avalo Therapeutics Launches Common Stock, Pre-Funded Warrants Offering; Terms Undisclosed

Avalo Therapeutics, Inc. (NASDAQ: AVTX) ("Avalo"), a clinical-stage biotechnology company fu
benzinga.com
Avalo Therapeutics Announces Topline Results From Phase 2 LOTUS Trial Evaluating Efficacy And Safety

Successfully met primary endpoint of HiSCR75 for both doses studied, demonstrating response rates of

Avalo Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
globenewswire.com
Avalo Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

WAYNE, Pa., May 05, 2026 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (NASDAQ: AVTX) (“Avalo”), a cl

Avalo Therapeutics Achieves Positive Topline Results in Phase 2 LOTUS Trial of Abdakibart (AVTX-009) in Moderate to Severe Hidradenitis Suppurativa
globenewswire.com
Avalo Therapeutics Achieves Positive Topline Results in Phase 2 LOTUS Trial of Abdakibart (AVTX-009)

WAYNE, Pa., May 05, 2026 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical sta

Avalo Therapeutics Purchases Optional Milestone Buyout
globenewswire.com
Avalo Therapeutics Purchases Optional Milestone Buyout

WAYNE, Pa., April 28, 2026 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX) (“Avalo”), a

benzinga.com
BTIG Reiterates Buy on Avalo Therapeutics, Maintains $40 Price Target

BTIG analyst Julian Harrison reiterates Avalo Therapeutics (NASDAQ:AVTX) with a Buy and maintains
benzinga.com
Wolfe Research Initiates Coverage On Avalo Therapeutics with Outperform Rating, Announces Price Targ

Wolfe Research analyst Andy Chen initiates coverage on Avalo Therapeutics (NASDAQ:AVTX) with a Ou

Brokerages Set Avalo Therapeutics, Inc. (NASDAQ:AVTX) Target Price at $42.25
defenseworld.net
Brokerages Set Avalo Therapeutics, Inc. (NASDAQ:AVTX) Target Price at $42.25

Avalo Therapeutics, Inc. (NASDAQ: AVTX - Get Free Report) has been assigned a consensus rating of "M

This Avalo Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
benzinga.com
This Avalo Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Mo

Wall Street analysts have changed outlooks on top stocks. For details on changes, check out analyst

Here Are Monday’s Top Wall Street Analyst Research Calls: Avis Budget, Carvana, Dow, Kratos Defense, Netflix, Northern Trust, PayPay,Twilio, Tyson Foods and More
247wallst.com
Here Are Monday’s Top Wall Street Analyst Research Calls: Avis Budget, Carvana, Dow, Kratos Defense,

Pre-Market Stock Futures: Futures are trading mixed as we get ready to kick off the first-quarter ea
benzinga.com
Citizens Initiates Coverage On Avalo Therapeutics with Market Outperform Rating, Announces Price Tar

Citizens analyst Jason Butler initiates coverage on Avalo Therapeutics (NASDAQ:AVTX) with a Marke